全文获取类型
收费全文 | 19284篇 |
免费 | 1201篇 |
国内免费 | 131篇 |
专业分类
耳鼻咽喉 | 330篇 |
儿科学 | 497篇 |
妇产科学 | 379篇 |
基础医学 | 2786篇 |
口腔科学 | 1667篇 |
临床医学 | 1430篇 |
内科学 | 4046篇 |
皮肤病学 | 453篇 |
神经病学 | 1289篇 |
特种医学 | 578篇 |
外科学 | 2267篇 |
综合类 | 84篇 |
一般理论 | 3篇 |
预防医学 | 2180篇 |
眼科学 | 256篇 |
药学 | 1389篇 |
1篇 | |
中国医学 | 194篇 |
肿瘤学 | 787篇 |
出版年
2023年 | 184篇 |
2022年 | 340篇 |
2021年 | 755篇 |
2020年 | 495篇 |
2019年 | 623篇 |
2018年 | 781篇 |
2017年 | 543篇 |
2016年 | 583篇 |
2015年 | 679篇 |
2014年 | 880篇 |
2013年 | 1068篇 |
2012年 | 1447篇 |
2011年 | 1690篇 |
2010年 | 906篇 |
2009年 | 703篇 |
2008年 | 1108篇 |
2007年 | 1099篇 |
2006年 | 923篇 |
2005年 | 807篇 |
2004年 | 692篇 |
2003年 | 611篇 |
2002年 | 515篇 |
2001年 | 392篇 |
2000年 | 360篇 |
1999年 | 326篇 |
1998年 | 153篇 |
1997年 | 132篇 |
1996年 | 124篇 |
1995年 | 85篇 |
1994年 | 81篇 |
1993年 | 64篇 |
1992年 | 145篇 |
1991年 | 137篇 |
1990年 | 96篇 |
1989年 | 117篇 |
1988年 | 113篇 |
1987年 | 80篇 |
1986年 | 93篇 |
1985年 | 75篇 |
1984年 | 59篇 |
1983年 | 54篇 |
1982年 | 35篇 |
1981年 | 30篇 |
1980年 | 39篇 |
1979年 | 47篇 |
1978年 | 30篇 |
1977年 | 31篇 |
1976年 | 33篇 |
1971年 | 30篇 |
1969年 | 29篇 |
排序方式: 共有10000条查询结果,搜索用时 328 毫秒
991.
992.
993.
994.
Johanna C. Bendell Tamara Sauri Antonio Cubillo Gracián Rafael Alvarez Carlos López-López Pilar García-Alfonso Maen Hussein Maria-Luisa Limon Miron Andrés Cervantes Clara Montagut Cristina Santos Vivas Alberto Bessudo Patricia Plezia Veerle Moons Johannes Andel Jaafar Bennouna Andre van der Westhuizen Leslie Samuel Simona Rossomanno Christophe Boetsch Angelika Lahr Izolda Franjkovic Florian Heil Katharina Lechner Oliver Krieter Herbert Hurwitz for the McCAVE Study Group 《The oncologist》2020,25(3):e451-e459
995.
Adriana Cunha VargasCatia Dell AgnoloWillian Augusto de MeloFernando Castilho PellosoLander dos SantosMaria Dalva de Barros CarvalhoSandra Marisa Pelloso 《Asian Pacific journal of cancer prevention》2020,21(1):55-62
Objective: This study aimed to analyze the trend in cervical cancer (ICD C53) mortality in Brazilian regions in women who are who are screened and not screened from 1996 to 2015. Methods: An epidemiological study, of time series of mortality from cervical cancer performed in 90,856 women under 24 years old (343 women), between 25 and 64 years old (32,703 women), and over 65 years old (10,909 women). The data from this research were collected from the DATASUS, from the SIM Health Surveillance Secretariat files, captured through TABNET selecting the resident population by gender and age group and ICD 10 C53 from 1996 to 2015. Results: Among women, 43.8% were white, and 76% had less than eight years of formal education. Polynomial regression showed an increasing trend in cervical cancer mortality in Brazil for women aged 15 - 24 years (p=0.01). Between 25 - 64 and 65 years or older it remained constant, but high (p=0.07; 0.99). The Northeast region pointed a growing trend in women aged 15 to 24 (p=0.01), 25 to 64 years (p=0.01) and 65 or older (p=0.001). The Northeast presented the highest average growth per year. In the Southeast, South and Midwest regions, decreasing trends were observed despite the high rates. The Joinpoint regression showed a 95% confidence interval, and that mortality from cervical cancer in the North region increased throughout the period analyzed. an increasing trend was observed from 1996 to 1998, whereas in the Midwest region, the trend remained stable throughout the period analyzed. The Federal District presented an upward trend from 1996 to 2015. In Brazil, an upward trend was observed throughout the whole period analyzed. Conclusions: Cervical cancer mortality in younger women is becoming more predominant, in addition to the high rate observed for women aged 65 or older. 相似文献
996.
Topical Treatment of Oral Mucositis in Cancer Patients: A Systematic Review of Randomized Clinical Trials
下载免费PDF全文
![点击此处可从《Asian Pacific journal of cancer prevention》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Geisa Sant AnaAna Gabriela Costa NormandoIsabela de Toledo Paula Elaine Diniz dos ReisEliete Neves Silva Guerra 《Asian Pacific journal of cancer prevention》2020,21(7):1851-1866
Background and Purpose: Evidence-based protocols of topical therapy for oral mucositis (OM) induced by chemoradiotherapy (CRT) are continuously established and updated. Thus, the present systematic review aims to evaluate the scientific literature in terms of effectiveness of topical treatment of OM in cancer patients undergoing CRT. Materials and Methods: This systematic review was based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Checklist. Randomized clinical trials were identified through electronic database searches on CINAHL, Cochrane Library, LILACS, Livivo, PubMed, SCOPUS, and Web of Science. Grey literature was also assessed on Google Scholar, Open Grey, and ProQuest. The risk of bias in the included studies was assessed by the Cochrane Collaboration Risk of Bias Tool. Results: Twenty-three randomized clinical trials (n=1169 patients) met the inclusion criteria. Twenty-three different topical agents were examined and categorized into five groups: analgesics (30.4%), natural agents (21.7%), other topical agents (21.7%), antimicrobial agents (17.4%), and growth factors (8.8%). Of the included studies, 50% presented a resolution of OM within 14 days. Topical natural agents yielded good results with average resolution time of 3–7 days. The included studies generally demonstrated that patients treated with mouthwashes presented superior benefits compared to the control, depending on OM severity. Conclusion: Topical agents effectively reduced the severity of OM lesions and pain intensity in patients receiving chemoradiotherapy, although the effects varied by agent type. However, the heterogeneity in the results of these topical intervention studies underscores the need for standardized clinical trial methodologies. Clinical Relevance: Topical agents were effective in patients with severe OM lesions receiving chemoradiotherapy and are a good alternative of home care in relation to pain control, reduction of inflammation and consequent improvement in quality of life. 相似文献
997.
998.
Fabio Luis-Silva Mayra Gonalves Menegueti Corina dos Reis Sepeda Bruno C. Petroski-Moraes Lucas Sato Leandro Moreira Peres Christiane Becari Anibal Basile-Filho Paulo R.B. Evora Olindo Assis Martins-Filho Maria Auxiliadora-Martins 《Medicine》2022,101(3)
Introduction:Septic shock is a lethal disease responsible for a large proportion of deaths in the Intensive Care Unit (ICU), even with therapy centered on fluid resuscitation, use of vasopressors and empirical antibiotic therapy applied within the first hour of diagnosis. Considering the multifactorial pathophysiology of septic shock and the mechanism of action of vasopressors, some patients may not respond adequately, which can lead to the maintenance of vasodilatation, hypotension and increased morbidity, and mortality. This protocol aims to verify whether the use of methylene blue in septic patients with an early diagnosis can contribute to an earlier resolution of a shock compared to standard treatment.Methods and analysis:This is a study protocol for a single-center randomized clinical trial design in an ICU of a tertiary university hospital. In this study, we intend to include 64 patients aged between 18 and 80 years with a diagnosis of septic shock, of any etiology, with up to 72 hours of evolution after volume restoration, using norepinephrine at a dose ≥0.2 μg/kg/min and vasopressin at a dose of 0.04 IU/min. After the initial approach, we will randomize patients into two groups, standard care, and standard care plus methylene blue. The sample size was calculated in order to show 30% differences in septic shock resolution between groups. The Research Ethics Committee approved the study, and all patients included will sign an informed consent form (Clinical registration: RBR-96584w4). 相似文献
999.
1000.
Iara Buriola Trevisan Ubiratan de Paula Santos Marceli Rocha Leite Aline Duarte Ferreira Bruna Spolador de Alencar Silva Ana Paula Coelho Figueira Freire Gabriel Faustino Santa Brigida Ercy Mara Cipulo Ramos Dionei Ramos 《Revista brasileira de otorrinolaringologia (English ed.)》2019,85(3):337-343
IntroductionBurnt sugarcane harvesting requires intense physical exertion in an environment of high temperature and exposure to particulate matter.ObjectiveTo evaluate the effects of burnt sugarcane harvesting on rhinitis symptoms and inflammatory markers in sugarcane workers.MethodsA total of 32 male sugarcane workers were evaluated with questionnaire for rhinitis symptoms, and for inflammatory markers on peripheral blood and nasal lavage, in the non-harvesting, and 3 and 6 months into the sugarcane harvesting period. Weather data and particulate matter fine concentrations were measured in the same day.ResultsThe particulate matter concentrations in sugarcane harvesting were 27 (23–33 μg/m3), 112 (96–122 μg/m3), and 63 (17–263 μg/m3); 24 h temperatures were 32.6 (25.4–37.4 °C), 32.3 (26.7–36.7 °C) and 29.7 (24.1–34.0 °C) and relative humidities were 45.4 (35.0–59.7%), 47.9 (39.1–63.0%), and 59.9 (34.7–63.2%) in the non-harvesting period, three and 6 months of the harvesting period. The age was 37.4 ± 10.9 years. The prevalence of rhinitis symptoms was significantly higher at 3 months of the harvesting period (53.4%), compared to non-harvesting period (26.7%; p = 0.039) and at 6 months into the harvesting period (20%; p = 0.006). Concentrations of interleukin 6 (IL-6) in nasal lavage increased after 3 months of the harvesting period compared to the non-harvesting period (p = 0.012). The presence of rhinitis symptoms, after 3 months of the harvesting period, was directly associated with blood eosinophils and inversely associated with neutrophils.ConclusionsAfter 3 months of work in burnt sugarcane harvesting the prevalence of rhinitis symptoms and IL-6 in nasal lavage increased. Furthermore, eosinophil counts were directly associated with the rhinitis symptoms in the period of higher concentration of particulate matter. 相似文献